Insights

Board Expansion Recent board addition of Raymond W. Cohen, a veteran medical device executive, suggests potential for strategic partnerships, advisory engagements, and stronger investor relations that can unlock introductions to larger OEMs and hospital networks.

Expanded Platform Cardiogenesis is evolving from a single laser therapy system toward combining laser treatment with autologous cell therapy in one delivery system, signaling opportunities to cross-sell integrated solutions to interventional cardiology and surgical teams.

Regulatory Advantage FDA approval for the Holmium:YAG laser system and CE marking in Europe position the company to target multi-region hospital accounts and leverage global sales conversations with CryoLife’s larger distribution footprint.

Refractory Angina Focus The TMR technology is recognized by major cardiovascular societies and targets patients refractory to conventional options, presenting a niche with HCP receptivity and fewer competing pathways, ideal for targeted outreach and KOL engagement.

Growth via CryoLife As a wholly owned CryoLife subsidiary with a lean team, Cardiogenesis can scale through CryoLife’s sales, clinical education, and service infrastructure to pursue larger hospital systems and regional accounts efficiently.

Similar companies to Cardiogenesis Corporation

Cardiogenesis Corporation Tech Stack

Cardiogenesis Corporation uses 4 technology products and services including Google Cloud CDN, Google Cloud, Nginx, and more. Explore Cardiogenesis Corporation's tech stack below.

  • Google Cloud CDN
    Content Delivery Network
  • Infrastructure As A Service
  • Nginx
    Web Servers
  • OpenResty
    Web Servers

Cardiogenesis Corporation's Email Address Formats

Cardiogenesis Corporation uses at least 3 email formats:
Cardiogenesis Corporation Email FormatsExamplePercentage
First_Last@cardiogenesis.comJohn_Doe@cardiogenesis.com
44%
FLast@cardiogenesis.comJDoe@cardiogenesis.com
45%
First.Last@cardiogenesis.comJohn.Doe@cardiogenesis.com
11%

Frequently Asked Questions

What is Cardiogenesis Corporation's phone number?

Minus sign iconPlus sign icon
You can contact Cardiogenesis Corporation's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cardiogenesis Corporation's official website and social media links?

Minus sign iconPlus sign icon
Cardiogenesis Corporation's official website is cardiogenesis.com and has social profiles on LinkedIn.

How much revenue does Cardiogenesis Corporation generate?

Minus sign iconPlus sign icon
As of October 2026, Cardiogenesis Corporation's annual revenue is estimated to be $1M - $10M.

What is Cardiogenesis Corporation's NAICS code?

Minus sign iconPlus sign icon
Cardiogenesis Corporation's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Cardiogenesis Corporation have currently?

Minus sign iconPlus sign icon
As of October 2026, Cardiogenesis Corporation has approximately 12 employees across 2 continents, including North America and Europe. Key team members include Cfo » Venture Capital Financing | Gaap & Sec Compliance | Early Stage Life Sciences Ventures: L. S. and General Manager: N. V. Explore Cardiogenesis Corporation's employee directory with LeadIQ.

What industry does Cardiogenesis Corporation belong to?

Minus sign iconPlus sign icon
Cardiogenesis Corporation operates in the Medical Equipment Manufacturing industry.

What technology does Cardiogenesis Corporation use?

Minus sign iconPlus sign icon
Cardiogenesis Corporation's tech stack includes Google Cloud CDN, Google Cloud, Nginx and OpenResty.

What is Cardiogenesis Corporation's email format?

Minus sign iconPlus sign icon
Cardiogenesis Corporation's email format typically follows the pattern of First_Last@cardiogenesis.com. Find more Cardiogenesis Corporation email formats with LeadIQ.
Cardiogenesis Corporation logo

Cardiogenesis Corporation

Medical Equipment ManufacturingGeorgia, United States11-50 Employees

Cardiogenesis Corporation, a wholly owned subsidiary of CryoLife since its 2011 acquisition, develops medical devices for cardiovascular treatment. Based in Kennesaw, Georgia, it operates in the medical equipment manufacturing sector and markets a laser-based system with disposable delivery components used to perform Transmyocardial Revascularization. 

The system is approved by the FDA for distribution in the United States and is CE-marked for Europe. Transmyocardial Revascularization targets patients with chronic stable angina who do not respond to medical management and for whom stenting or bypass surgery is no longer an option, with long-term results described as demonstrating efficacy. The company is expanding the platform by integrating laser therapy with autologous cell delivery in a single system, and in December 2025 appointed Raymond W. Cohen to its Board of Directors.

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Cardiogenesis Corporation's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.